Lowenthal Richard E's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Aug 22, 2025
- Accession no.
- 0001415889-25-022761
- Filed
- Aug 22, 2025
- Trade date
- Aug 21, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $724.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lowenthal Richard ECIK 0001378550 | Director, Officer (PRESIDENT AND CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | Common Stock | SSaleDisposed | −50,000 | $14.49 | −$724,500 | 1,196,494 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.